| 
May 17, 2023
Horizon Therapeutics is yesterday's top mover after declining 14.17%
Leading equity indices in the US declined as Dow Jones shed 1% and closed at 33,000. S&P 500 was down 0.64% before closing the session at 4,110.
Today's price action is taking place amid mixed market indicators – United States Building Permits (Apr) released today at 12:30 UTC with a figure of 1.42 million, while the previous figure was 1.44 million.
Assets that recorded the greatest percentage change in relation to their peers are designated as "Top Movers" with 's most active healthcare stocks listed below.
Horizon Therapeutics lost 14.17% during yesterday's session; goes up in pre-market trading (+1.44% to $97.73)
More of the same from yesterday's session: after ending Monday at $112.25, Horizon Therapeutics Public Limited Company declined to $90.61 yesterday before closing at $96.34, thereby losing 14.17% in total. Horizon Therapeutics is currently trading with a market cap of $22 billion with an average daily trading volume of 2.84 million shares. So far this year, it has been doing worse than the Nasdaq by 29.08%.
Maravai LifeSciences suffers weak session with 10.73% loss; downside halted at $12.04
Early in yesterday's session, Maravai LifeSciences dropped to $12.04 from $15 at the end of Monday, before closing at $13.39. During the session, it lost 10.73%. Maravai LifeSciences has a market cap of $2.75 billion with an average daily volume of 3.97 million shares. So far this year, it has been under-performing the Nasdaq by 17.78%.
Yesterday's slide leaves Denali Therapeutics traders hoping for a bounce
After ending Monday at $32.02, Denali Therapeutics dropped to $29.15 early in yesterday's session and closed at $29.3. In total, it lost 8.49%. Denali Therapeutics's market cap is currently $4 billion with an average daily volume of 724,642 shares. So far this year, it has been doing worse than the Nasdaq by 10.32%.
